The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider ...read more
Bioventus, which offers orthobiologics products for musculoskeletal conditions, raised $104 million by offering 8 million shares at $13, below the range of $16 to $18. The company offered 0.7 million more shares than anticipated. At pricing, Bioventus commands a...read more
Updated Monday, 2/8. The IPO market is buzzing with 15 IPOs slated to raise $4.0 billion in the week ahead, led by dating app Bumble’s billion-dollar offering. Bumble (BMBL) plans to raise $1.7 billion at a $7.5...read more
Bioventus, which offers orthobiologics products for musculoskeletal conditions, announced terms for its IPO on Thursday. The company had previously filed to raise $150 million at a $575 million market cap in July 2016, but withdrew the offering the...read more
US IPO Weekly Recap: IPO frenzy brings the year’s largest deal and biggest pop in a 17 IPO week
The IPO frenzy continued this past week as 17 IPOs and 26 SPACs entered the public market. Headlining the week were dating app Bumble (BMBL), which completed the year's largest deal so far, and Chinese cloud services provider ...read more
Orthobiologic products developer Bioventus prices IPO at $13, below the range
Bioventus, which offers orthobiologics products for musculoskeletal conditions, raised $104 million by offering 8 million shares at $13, below the range of $16 to $18. The company offered 0.7 million more shares than anticipated. At pricing, Bioventus commands a...read more
US IPO Week Ahead: Bumble’s billion-dollar deal leads a buzzy 15 IPO week
Updated Monday, 2/8. The IPO market is buzzing with 15 IPOs slated to raise $4.0 billion in the week ahead, led by dating app Bumble’s billion-dollar offering. Bumble (BMBL) plans to raise $1.7 billion at a $7.5...read more
Orthobiologic products developer Bioventus sets terms for $125 million IPO
Bioventus, which offers orthobiologics products for musculoskeletal conditions, announced terms for its IPO on Thursday. The company had previously filed to raise $150 million at a $575 million market cap in July 2016, but withdrew the offering the...read more